Physician profile
Simon R Brooks
NPI 1588658033
$7,934.10
in general payments reported to CMS, 2019-2025
31 companies · $1,618 in 2025
The $1,618 reported for 2025 was more than what 80% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $813 · 2020: $1,031 · 2021: $763 · 2022: $1,103 · 2023: $1,091 · 2024: $1,514 · 2025: $1,618.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,223.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,223.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $901.82 | 2019-2025 | Farxiga, Wainua |
| Pfizer INC. | $794.04 | 2019-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $711.41 | 2019-2025 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $653.89 | 2019-2025 | Camzyos, Eliquis |
| Boston Scientific Corporation | $610.50 | 2019-2025 | Watchman, Avvigo Guidance System, Emblem Mri S-Icd |
| Novartis Pharmaceuticals Corporation | $597.93 | 2019-2025 | |
| Amarin Pharma, INC. | $500.88 | 2019-2023 | |
| Abiomed | $446.70 | 2020-2025 | Impella |
| Amgen INC. | $422.31 | 2019-2025 | Repatha, Repatha |
| Shockwave Medical, INC | $363.48 | 2021-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Endologix LLC | $275.34 | 2024 | Torus Stent Graft System, Endocross Device |
| Boehringer Ingelheim Pharmaceuticals, INC. | $266.51 | 2019-2025 | Jardiance |
| Abbott Laboratories | $225.47 | 2021-2025 | Confirm Rx, Assurity, Diamondback Coronary |
| Merck Sharp & Dohme LLC | $185.82 | 2021-2025 | Verquvo |
| Cardiovascular Systems INC. | $129.38 | 2019-2022 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $126.84 | 2020-2021 | |
| Medtronic, INC. | $122.46 | 2022-2024 | Azure Xt Dr Mri Surescan, Corevalve Evolut R |
| Janssen Pharmaceuticals, INC | $100.20 | 2020-2024 | Xarelto |
| Philips North America LLC | $95.45 | 2020-2025 | (Cm9) Amb Mon & Diag Und, Ambulatory Monitoring & Diagnostics Undivided, (5091) Amb Mon & Diag Und |
| Astellas Pharma US INC | $75.00 | 2019 | |
| Esperion Therapeutics, INC. | $54.84 | 2022-2025 | Nexletol |
| Irhythm Technologies, INC. | $43.11 | 2023-2024 | Zio Xt Patch, Zio Monitor |
| Penumbra, INC. | $37.48 | 2022-2023 | Indigo System |
| Arbor Pharmaceuticals, INC. | $33.81 | 2019-2021 | |
| Veryan Medical Incorporated | $30.45 | 2023 | Biomimics 3d Vascular Stent System |
| Regeneron Healthcare Solutions, INC. | $30.35 | 2019 | |
| Cardiva Medical, INC. | $22.30 | 2024 | Cardiva Vascade Mvp Vvcs 6-12f |
| Cardinal Health 200 LLC | $21.67 | 2019 | |
| Inari Medical, INC. | $21.04 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Chiesi USA, INC. | $18.90 | 2021 | |
| Medtronic Vascular, INC. | $14.72 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Simon Brooks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.